Head And Neck Squamous Cell Carcinoma Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
TIL | D | Instil Bio, Inc. | 1.79 | |
ACHL | F | Achilles Therapeutics plc | -2.81 | |
TOVX | F | Theriva Biologics, Inc. | 0.00 |
Related Industries: Biotechnology
Related Stock Lists:
Cancer
Biopharmaceutical
Cancer Immunotherapy
Clinical Medicine
Medicine
Melanoma
Advanced Non Small Cell Lung Cancer
Antibiotics
Antineoplastic Drugs
Bacterial Disease
Bladder Cancer
Breakthrough Therapy
Cancer Treatment
Cell Therapy
Cervical Cancer
Clostridium Difficile Infection
Colorectal Cancer
Cutaneous Squamous Cell Carcinoma
Diarrhea
Disease
Related Industries:
Biotechnology
Related Stock Lists:
Cancer
Biopharmaceutical
Cancer Immunotherapy
Clinical Medicine
Medicine
Melanoma
Advanced Non Small Cell Lung Cancer
Antibiotics
Antineoplastic Drugs
Bacterial Disease
Bladder Cancer
Breakthrough Therapy
Cancer Treatment
Cell Therapy
Cervical Cancer
Clostridium Difficile Infection
Colorectal Cancer
Cutaneous Squamous Cell Carcinoma
Diarrhea
Disease
- Head And Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a type of cancer that develops in the squamous cells of the head and neck region. It is the most common type of head and neck cancer and can affect any part of the head and neck, including the mouth, nose, throat, larynx, and salivary glands. Symptoms of HNSCC can include a lump or sore in the mouth or throat that does not heal, a sore throat that does not go away, difficulty swallowing, and a hoarse voice. Treatment for HNSCC typically involves surgery, radiation therapy, and/or chemotherapy.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles